Synexus Clinical Research US Inc — Dallas, Texas

Synexus Clinical Research US Inc is a clinical research site located in Dallas, Texas, United States 75234.

Crixeo Clinical Trials Trust Score: 16/100 (FAILING). This profile has not yet been claimed by the site owner.

Synexus Clinical Research US Inc has participated in 9 clinical trials with 2 currently active.

Therapeutic areas: Gastroparesis, Diabetes Mellitus, Participants With or Without Stable Co-morbidities Associated With Progression to Severe COVID-19 at Different Stages of the Protocol.

Sponsors: Allergan, Janssen Vaccines & Prevention B.V., AbbVie.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Dallas

Browse all research sites in Texas · View every site in Dallas

Sponsor Feasibility Report

Trust Score: 16/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Synexus Clinical Research US Inc?

Synexus Clinical Research US Inc has a Crixeo Trust Score of 16/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Synexus Clinical Research US Inc conducted?

Synexus Clinical Research US Inc has 9 clinical trials on record, with 2 currently active. Their work covers Gastroparesis, Diabetes Mellitus, Participants With or Without Stable Co-morbidities Associated With Progression to Severe COVID-19 at Different Stages of the Protocol.

Is Synexus Clinical Research US Inc accredited by Crixeo Clinical Trials?

Synexus Clinical Research US Inc has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Synexus Clinical Research US Inc?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.